The anticonvulsive drug lamotrigine blocks neuronal α4β2 nicotinic acetylcholine receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 2, 2010, Pages 401-408

  Zheng, Chao ^a,b,c   Yang, Kechun ^b   Liu, Qiang ^b   Wang, Meng Ya ^c   Shen, Jianxin ^a   Vallés, A Sofía ^d   Lukas, Ronald J ^b   Barrantes, Francisco J ^d   Wu, Jie ^a,b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c WANNAN MEDICAL COLLEGE   (China)

^d UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; LAMOTRIGINE; NICOTINIC RECEPTOR ALPHA4BETA2;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; CELL LINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; NEURONS; NICOTINIC ANTAGONISTS; PATCH-CLAMP TECHNIQUES; RATS; RECEPTORS, NICOTINIC; TRIAZINES; VENTRAL TEGMENTAL AREA;

EID: 78149248492     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.171108     Document Type: Article

References (38)

1. Beck O, Ohman I, and Nordgren HK (2006) Determination of lamotrigine and its metabolites in human plasma by liquid chromatography-mass spectrometry. Ther Drug Monit 28:603-607.
2. Bertrand D, Picard F, Le Hellard S, Weiland S, Favre I, Phillips H, Bertrand S, Berkovic SF, Malafosse A, and Mulley J (2002) How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia 43:112-122.
3. Blanpied TA, Boeckman FA, Aizenman E, and Johnson JW (1997) Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol 77:309-323.
4. Brodtkorb E and Picard F (2006) Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Behav 9:515-520.
5. Buchanan N (1996) The use of lamotrigine in juvenile myoclonic epilepsy. Seizure 5:149-151.
6. Cheung H, Kamp D, and Harris E (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13:107-112.
7. Clemens B, Piros P, Bessenyei M, Tóth M, Hollódy K, and Kondákor I (2008) Imaging the cortical effect of lamotrigine in patients with idiopathic generalized epilepsy: a low-resolution electromagnetic tomography (LORETA) study. Epilepsy Res 81:204-210.
8. De Fusco M, Becchetti A, Patrignani A, Annesi G, Gambardella A, Quattrone A, Ballabio A, Wanke E, and Casari G (2000) The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 26:275-276.
9. Dion MH, Novotny EJ, Jr., Carmant L, Cossette P, and Nguyen DK (2007) Lamotrigine therapy of epilepsy with Angelman's syndrome. Epilepsia 48:593-596.
10. Doose DR, Brodie MJ, Wilson EA, Chadwick D, Oxbury J, Berry DJ, Schwabe S, and Bialer M (2003) Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients. Epilepsia 44:917-922.
11. Eaton JB, Peng JH, Schroeder KM, George AA, Fryer JD, Krishnan C, Buhlman L, Kuo YP, Steinlein O, and Lukas RJ (2003) Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells. Mol Pharmacol 64:1283-1294.
12. Ghosheh O, Vashishtha SC, and Hawes EM (2001) Formation of the quaternary ammonium-linked glucuronide of nicotine in human liver microsomes: identification and stereoselectivity in the kinetics. Drug Metab Dispos 29:1525-1528.
13. Gotti C and Clementi F (2004) Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74:363-396.
14. Hogg RC, Raggenbass M, and Bertrand D (2003) Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol 147:1-46.
15. Labiner DM, Ettinger AB, Fakhoury TA, Chung SS, Shneker B, Tatum Iv WO, Mitchell Miller J, Vuong A, Hammer AE, and Messenheimer JA (2009) Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Epilepsia 50:434-442.
16. MacDonald JF, Miljkovic Z, and Pennefather P (1987) Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol 58:251-266.
17. Magnusson A, Nakken KO, and Brubakk E (1996) Autosomal dominant frontal epilepsy. Lancet 347:1191-1192.
18. Marszalec W and Narahashi T (1993) Use-dependent pentobarbital block of kainate and quisqualate currents. Brain Res 608:7-15.
19. Matsuo F (1999) Lamotrigine. Epilepsia 40:S30-S36.
20. Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, and Manasco P (1997) Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med 337:1807-1812.
21. Moulard B, Picard F, le Hellard S, Agulhon C, Weiland S, Favre I, Bertrand S, Malafosse A, and Bertrand D (2001) Ion channel variation causes epilepsies. Brain Res Brain Res Rev 36:275-284.
22. Paxinos G and Watson C (1998) The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego.
23. Phillips HA, Favre I, Kirkpatrick M, Zuberi SM, Goudie D, Heron SE, Scheffer IE, Sutherland GR, Berkovic SF, Bertrand D, et al. (2001) CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 68:225-231.
24. Rozycka A, Steinborn B, and Trzeciak WH (2009) The 1674+11C>T polymorphism of CHRNA4 is associated with juvenile myoclonic epilepsy. Seizure 18:601-603.
25. Steinlein OK, Magnusson A, Stoodt J, Bertrand S, Weiland S, Berkovic SF, Nakken KO, Propping P, and Bertrand D (1997) An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 6:943-947.
26. Trevathan E, Kerls SP, Hammer AE, Vuong A, and Messenheimer JA (2006) Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Pediatrics 118:e371-378.
27. Vallés AS, Garbus I, Antollini SS, and Barrantes FJ (2008) A novel agonist effect on the nicotinic acetylcholine receptor exerted by the anticonvulsive drug Lamotrigine. Biochim Biophys Acta 1778:2395-2404.
28. Vallés AS, Garbus I, and Barrantes FJ (2007) Lamotrigine is an open-channel blocker of the nicotinic acetylcholine receptor. Neuroreport 18:45-50.
29. Wu J, Kuo YP, George AA, Xu L, Hu J, and Lukas RJ (2004) beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. J Biol Chem 279:37842-37851.
30. Wu J, Liu Q, Yu K, Hu J, Kuo YP, Segerberg M, St John PA, and Lukas RJ (2006) Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors. J Physiol 576:103-118.
31. Xiao C, Yang KC, Zhou CY, Jin GZ, Wu J, and Ye JH (2009) Nicotine modulates GABAergic transmission to dopaminergic neurons in substantia nigra pars compacta. Acta Pharmacol Sin 30:851-858.
32. Xie X, Lancaster B, Peakman T, and Garthwaite J (1995) Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones. Pflugers Arch 430:437-446.
33. Yang K, Hu J, Lucero L, Liu Q, Zheng C, Zhen X, Jin G, Lukas RJ, and Wu J (2009a) Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons. J Physiol 587:345-361.
34. Yang KC, Jin GZ, and Wu J (2009b) Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology. Acta Pharmacol Sin 30:740-751.
35. Yu KD, Liu Q, Wu J, and Lukas RJ (2009) Kinetics of desensitization and recovery from desensitization for human alpha4beta2-nicotinic acetylcholine receptors stably expressed in SH-EP1 cells. Acta Pharmacol Sin 30:805-817.
36. Zhao X, Salgado VL, Yeh JZ, and Narahashi T (2004) Kinetic and pharmacological characterization of desensitizing and non-desensitizing glutamate-gated chloride channels in cockroach neurons. Neurotoxicology 25:967-980.
37. Zheng C, Wang MY, Liu Q, Wakui M, Whiteaker P, Lukas RJ, and Wu J (2009) U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line. J Neurochem 108:1526-1538.
38. Zona C and Avoli M (1997) Lamotrigine reduces voltage-gated sodium currents in rat central neurons in culture. Epilepsia 38:522-525.